Screener/Healthcare/Biotechnology

TSHA

Taysha Gene Therapies, Inc.NASDAQ
$4.13-0.41 (-9.14%)
Small CapPenny StockUnder $5Healthcare
$1.05
$6.02
$4.08
$4.52
EPS (TTM)$-0.33
P/E Ratio—
Dividend Yield—
Market Cap$1.10B
Volume4.57M
Prev Close$4.54
Revenue & Operating Income
Revenue
Operating Income
Net Income
Positive
Negative
Free Cash Flow
Positive
Negative
Gross Profit & Operating Expenses
Gross Profit
Operating Expenses
Earnings Per Share
Positive
Negative
Balance Sheet
Total Assets
Total Liabilities
Cash & Equivalents
Cash & Equivalents
Shares Outstanding
Shares Outstanding
Margins
Gross Margin
Operating Margin
Net Margin

Quarterly Results

QuarterRevenueNet IncomeEPSGross MarginNet Margin
Q3 '25$0-$32.7M$-0.09——
Q2 '25$2.0M-$26.9M$-0.09—-1353.6%
Q1 '25$2.3M-$21.5M$-0.08—-935.2%
Q4 '24$2.0M-$18.8M$-0.07—-929.0%
Q3 '24$1.8M-$25.5M$-0.10—-1427.5%
Q2 '24$1.1M-$20.9M$-0.09—-1882.0%
Q1 '24$3.4M-$24.1M$-0.10—-705.4%
Q4 '23$3.6M$47.7M$0.92—1324.7%
Get Your Daily Market Recap